EC Clinical and Medical Case Reports

Adrenal insufficiency (AI) is an uncommon medical condition characterized by a disorder of the adrenal glands which results in insufficient secretion of glucocorticoids and mineralocorticoids, either in the basal state or during times of stress. Can be due to a primary cause like adrenal failure itself or secondary to a disturbance in the hypothalamic-pituitary-adrenal axis (HPA). The impact of the life-threatening condition of adrenal insufficiency in a stress response which is called Addisonian crisis, and the emergent significance of a proper treatment by optimizing cortisol replacement therapy is adopted in a case of 66-year-old female, who presented with an unexplained weight loss, lack of energy, failure to thrive and decreased appetite. She had lost close to 20% of her body mass, which was quite worrying. MRI of the pituitary gland showed a small adenoma.

 Keywords: Adrenal Insufficiency; Addison’s Disease; Adrenal Crisis; Pituitary Adenoma

1. Kumar R and Wassif WS. “Adrenal insufficiency”. Journal of Clinical Pathology 75 (2022): 435- 442.
2. Mason AS., et al. “Epidemiological and clinical picture of Addison's disease”. Lancet 2 (1968): 744-747.
3. Bates AS., et al. “The effect of hypopituitarism on life expectancy”. The Journal of Clinical Endocrinology and Metabolism 81 (1996): 1169-1172.
4. Nilsson B., et al. “Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality”. The Journal of Clinical Endocrinology and Metabolism 85 (2000): 1420-1425.
5. Regal M., et al. “Prevalence, and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain”. Clinical Endocrinology 55 (2001): 735-740.
6. Shivaprasad C. “Sheehan's syndrome: newer advances”. Indian Journal of Endocrinology and Metabolism3 (2011): S203-S207.
7. Alexandraki KI., et al. “Adrenal Insufficiency”. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext South Dartmouth (MA): MDText.com, Inc (2000).
8. Kazlauskaite R., et al. “Corticotropin test for Hypothalamic-Pituitary-Adrenal Insufficiency: A Metanalysis”. The Journal of Clinical Endocrinology and Metabolism11 (2008): 4245-4253.
9. Lovas K and Husebye ES. “Replacement therapy for Addison's disease: recent developments”. Expert Opinion on Investigational Drugs4 (2008): 497-509.
10. Reimondo G., et al. “Secondary hypoadrenalism”. Pituitary2 (2008): 147-154.
11. Lebbe M and Arlt W. “What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?” Clinical Endocrinology 78 (2013): 497-502.
12. Hagg E., et al. “Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency”. Clinical Endocrinology 26 (1987): 221-226.
13. Dickstein G., et al. “Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test”. The Journal of Clinical Endocrinology and Metabolism 72 (1991): 773-778.
14. Schlaghecke R., et al. “The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin- releasing hormone”. The New England Journal of Medicine 326 (1992): 226-230.